Case File
efta-efta00714273DOJ Data Set 9OtherFrom: Daniel Gelemter
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00714273
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Daniel Gelemter
To: Jeffrey Epstein <[email protected]>
Subject: Re: numbers follow-up
Date: Thu, 15 Oct 2015 03:04:47 +0000
Hi Jeffery -- Fair enough; we could accept that if you'd make it 65-35 above 20M and 80-20 above 50M, and if
we could close this right away.
Regards,
Dan
On Wed, Oct 14, 2015 at 7:13 PM, jeffrey E. <jeevacation®gmail.com> wrote:
better
but too complex , for ex , 400k . first everyone gets their money back, and the split is . 50 50
untl 20 million 60 .40 up until 40. 70 30 above 50. the larger amounts in your favor of course
On Wed, Oct 14, 2015 at 4:55 PM, Daniel Gelemter <
wrote:
Dear Jeffrey - Regarding our conversation yesterday, we'd propose the following for a 51M investment:
Any sale at or above $50M, the investor gets 20%
Any sale between 530M and $50M, the investor gets 22%
Any sale at or below 530M, and the investor's share as a percentage is calculated as .09X'2 - 4.6X + 80, where X is the sale price in
millions.
This will guarantee a return on the investment for sales as low as $13M (which would produce a 10% return). A $4M sale would return
the investor 52.5M, a $1OM sale would return $4.3M, etc.
Would welcome your thoughts and your investment.
Regards,
Dan
please note
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
JEE
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacation®gmail.com, and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00714273
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.